Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corporation (NYSE: CHE) is a Cincinnati-based holding company that operates two distinct businesses: VITAS Healthcare and Roto-Rooter. This news page aggregates press releases and third-party coverage related to Chemed’s hospice operations and plumbing and drain cleaning services, giving investors and observers a single place to review company developments.
VITAS Healthcare is described by the company as the nation’s largest provider of end-of-life hospice care. News about VITAS often covers quarterly financial results, trends in net patient revenue, average daily census, admissions, Medicare reimbursement dynamics, and Medicare Cap billing limitations, particularly in key markets such as Florida and California. Updates can also include regulatory milestones, such as Certificates of Need in new counties, and changes in leadership at the VITAS level.
Roto-Rooter is characterized as the nation’s leading provider of plumbing and drain cleaning services. Coverage related to this segment typically includes segment revenue performance, commercial and residential demand trends, and results in service categories such as plumbing, drain cleaning, excavation, and water restoration. Company communications also discuss how Roto-Rooter operates through branches, independent contractors, franchisees, and licensed master franchisees in several countries.
Chemed regularly issues announcements about quarterly earnings, guidance revisions, dividend declarations, stock repurchase authorizations, and participation in healthcare and home care conferences. This news feed allows readers to follow how VITAS and Roto-Rooter contribute to consolidated results, how management responds to reimbursement and demand conditions, and how capital allocation decisions such as dividends and buybacks evolve over time.
For anyone tracking CHE, this page provides a convenient way to review historical and recent news items related to the company’s hospice care and plumbing and drain cleaning operations.
Chemed Corporation (NYSE: CHE) reported its first-quarter financial results for 2023, showing a 5.6% increase in revenue to $560 million. GAAP diluted EPS was $3.58, while adjusted diluted EPS slightly rose by 0.6% to $4.82. The VITAS segment generated $310 million in net patient revenue, a 3.8% increase, despite a 10.5% decline in net income and adjusted EBITDA, largely due to Medicare sequestration cuts. Roto-Rooter saw revenue growth of 7.9% to $250 million and a 9.3% increase in net income. Chemed maintained a strong cash position of $58.1 million and reduced its term loan to $21.3 million. Management plans to update 2023 earnings guidance in June.
Chemed Corporation (NYSE: CHE) will announce its financial results for Q1 2023 on April 26, 2023, after market close. A conference call is scheduled for April 27, 2023, at 10 a.m. ET to discuss the results and provide business updates. Interested parties can join through the investor relations section of Chemed’s website or via teleconference. A replay of the call will be available two hours post-conclusion. Chemed operates VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing and drain cleaning service provider.
Chemed Corporation (NYSE:CHE) announced a virtual presentation at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 1:20 p.m. (ET). The presentation will be streamed live and can be accessed on the company's website, www.chemed.com. Following the live event, a replay will be available within 24 hours and accessible for 90 days.
Chemed, headquartered in Cincinnati, Ohio, operates two subsidiaries: VITAS Healthcare, the largest end-of-life hospice provider, and Roto-Rooter, a leading plumbing service company. The announcement highlights Chemed's commitment to transparency and investor relations.
Chemed Corporation (NYSE: CHE) released its fourth-quarter results for 2022, reporting a revenue increase of 1.0% to $547 million. The company’s GAAP diluted EPS stood at $4.13, while adjusted diluted EPS rose 2.7% to $5.39. VITAS Healthcare segment revenue dropped by 2.5% to $308 million, with declines in patient admissions and average daily census. In contrast, Roto-Rooter’s revenue increased by 6.1% to $239 million, driven by a rise in both residential and commercial services. For 2023, VITAS anticipates revenue growth of 6.0% to 7.0%, while Roto-Rooter is expected to grow by 5.0% to 5.5%. The company also repurchased 25,000 shares for $13 million.
Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 38-cents per share, to be paid on March 17, 2023, to shareholders on record as of February 27, 2023. This dividend matches the amount paid in December 2022 and marks the company's 207th consecutive quarterly dividend in its 50 years as a public entity. Chemed Corporation operates two subsidiaries: VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, a leading plumbing services company.
Chemed Corporation (NYSE: CHE) has announced that it will release its financial results for the fourth quarter ended December 31, 2022, on February 23, 2023, post-market close. A conference call will be held on February 24, 2023, at 10 a.m. ET to discuss the quarterly results and provide a business update. Investors can access the conference call via the investor relations section of Chemed's website. Chemed operates VITAS Healthcare, the largest provider of end-of-life hospice care, and Roto-Rooter, the leading plumbing and drain cleaning service provider in the nation.
Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2022 Virtual Home Care Conference on Tuesday, December 5, 2022, at 10:40 AM ET. The live presentation will be webcast and accessible through the Chemed website, with a replay available within 24 hours for 90 days. Chemed operates VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, the leading plumbing service. Investors should note that statements made during the presentation may contain forward-looking information, subject to risks and uncertainties.
Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 38-cents per share, payable on December 5, 2022, to shareholders of record as of November 14, 2022. This dividend is consistent with that paid in September 2022 and marks the 206th consecutive quarterly dividend in the company's history as a public entity spanning 51 years. Chemed operates two key subsidiaries: VITAS Healthcare and Roto-Rooter.
Chemed Corporation (NYSE: CHE) reported a 2.3% decline in revenue to $526 million in Q3 2022, with GAAP EPS at $3.78. Adjusted diluted EPS decreased by 6.3% to $4.74. The VITAS segment saw a 6.6% drop in net patient revenue to $297 million, with significant declines in admissions (16.6%) and average daily census (4.4%). Conversely, Roto-Rooter revenue rose 3.9% to $230 million, while adjusted EBITDA increased 5.7% to $69.5 million. Cash and equivalents stood at $7.8 million, with $101 million in debt. Share repurchases totaled 50,000 shares for $23.9 million.
Chemed Corporation (NYSE:CHE) announced its upcoming presentation at the 31st Annual Credit Suisse Healthcare Conference on November 9, 2022, at 2:00 p.m. (PST). The event will take place at The Terranea Resort in Rancho Palos Verdes, CA, and will be available via live webcast on the Chemed website. A replay will be accessible for 90 days. Chemed operates two main subsidiaries: VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing service provider.